Iron Refractory Iron Deficiency Anemia in Dizygotic Twins Due to a Novel TMPRSS6 Gene Mutation in Addition to Polymorphisms Associated With High Susceptibility to Develop Ferropenic Anemia
Open Access
- 19 April 2017
- journal article
- case report
- Published by SAGE Publications in Journal of Investigative Medicine High Impact Case Reports
- Vol. 5 (2)
Abstract
Iron refractory iron deficiency anemia (IRIDA) is an autosomal recessive ferropenic anemia. Its hypochromic microcytic pattern is associated with low transferrin saturation, normal-high ferritin, and inappropriately high hepcidin level. This entity is caused by mutants of the TMPRSS6 gene that encodes the protein matriptase II, which influences hepcidin expression, an iron metabolism counterregulatory protein. We report two 29-year-old dizygotic female twins with ferropenic, hypochromic microcytic anemia with 20 years of evolution, refractory to oral iron therapy. After exclusion of gastrointestinal etiologies, IRIDA diagnosis was suspected and a novel mutation in the TMPRSS6 gene was identified. It was found in intron 11 (c.1396+4 A>T) and seems to affect the gene expression. In addition, 3 polymorphisms already associated with a higher risk of developing iron deficiency anemia were also found (D521D, V736A, and Y739Y). Our case reports an undescribed mutation causing IRIDA and supports the hypothesis that this clinical syndrome may be more common than previously thought and its genetics more heterogeneous than initially described.Keywords
This publication has 20 references indexed in Scilit:
- Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemiaTherapeutic Advances in Hematology, 2014
- How I treat unexplained refractory iron deficiency anemiaBlood, 2014
- Iron refractory iron deficiency anemiaHaematologica, 2013
- Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemiaAmerican Journal of Hematology, 2013
- Two novel mutations in the tmprss6 gene associated with iron‐refractory iron‐deficiency anaemia (irida) and partial expression in the heterozygous formBritish Journal of Haematology, 2012
- Successful treatment with low‐dose gemtuzumab ozogamicin in combination chemotherapy followed by stem cell transplantation for children with refractory acute myeloid leukaemiaBritish Journal of Haematology, 2012
- Responsiveness to oral iron and ascorbic acid in a patient with IRIDABlood Cells, Molecules, and Diseases, 2012
- Increased susceptibility to iron deficiency of Tmprss6-haploinsufficient miceBlood, 2010
- Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993–2005Public Health Nutrition, 2009
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)Nature Genetics, 2008